Tag:
Serada
Latest Headlines
Latest Headlines
UPDATED: Depomed shares crater on another Phase III miss for hot-flash drug
Depomed ( $DEPO ) disappointed in its third shot at a Phase III win for its drug Serada as a treatment for menopausal hot flashes, but the Menlo Park, CA-based firm's executives have given no
Will Abbott end up marketing Depomed's Gralise?
What if you had a new drug, but no one to sell it? That's the predicament faced by Depomed, whose shingles-pain drug Gralise won FDA approval Friday. The company had a licensing deal with Solvay
Depomed readies another Phase III for Serada
Depomed is hoping that the third time proves to be the charm for Serada, its experimental drug for hot flashes. Last October the developer's stock price was pounded after it unveiled data from two
Depomed shares tank on disappointing hot-flash data
Investors quickly mugged Depomed shares ( DEPO ) this morning after hearing that two late-stage trials of Serada--intended to treat menopausal hot flashes--managed to successfully achieve only one of
